Using nomograms to predict the presence of papillary thyroid carcinoma
- PMID: 37588738
- PMCID: PMC10425651
- DOI: 10.21037/tcr-23-597
Using nomograms to predict the presence of papillary thyroid carcinoma
Keywords: Papillary thyroid cancer (PTC); nomogram; ultrasound (US).
Conflict of interest statement
Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-23-597/coif). FAV reports consultancy fees received from Sanofi and GE Healthcare (all fees paid to employer) as well as speaker honoraria from AstraZeneca (all fees paid to employer). EFSvV has no conflicts of interest to declare.
Comment on
-
Development and validation of the nomogram based on ultrasound, thyroid stimulating hormone, and inflammatory marker in papillary thyroid carcinoma: a case-control study.Transl Cancer Res. 2023 Mar 31;12(3):490-501. doi: 10.21037/tcr-22-2478. Epub 2023 Mar 17. Transl Cancer Res. 2023. PMID: 37033338 Free PMC article.
References
-
- Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26:1-133. 10.1089/thy.2015.0020 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources